An estrogenic effect of 5α-androstane-3β, 17β-diol on the behavioral response to stress and on CRH regulation

Neuropharmacology

Volumn 54, Issue 8, 2008, Pages 1233-1238

  Huang, Qian ^a   Zhu, Hong ^a   Fischer, David F ^b   Zhou, Jiang Ning ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b BioFocus DPI   (United Kingdom)

Author keywords

5 Androstane 3 , 17 diol (3 diol); AVP; CRH; Forced swim test; Hypothalamus; Quantitative RT PCR; Reporter assays

Indexed keywords

3BETA ANDROSTANEDIOL; ARGIPRESSIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; ESTROGEN RECEPTOR; MESSENGER RNA; TAMOXIFEN; ANDROSTANEDIOL; ANTIESTROGEN; ESTROGEN; LUCIFERASE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN ACTIVITY; HORMONE RESPONSE; HYPOTHALAMUS; IMMOBILIZATION; IN VITRO STUDY; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRESS; ANIMAL; CHO CELL; CRICETULUS; GENETIC TRANSFECTION; GENETICS; HAMSTER; MENTAL STRESS; METABOLISM; PROMOTER REGION; PSYCHOLOGICAL ASPECT; SPRAGUE DAWLEY RAT; SWIMMING;

ANDROSTANE-3,17-DIOL; ANIMALS; ARGININE VASOPRESSIN; BEHAVIOR, ANIMAL; CHO CELLS; CORTICOTROPIN-RELEASING HORMONE; CRICETINAE; CRICETULUS; ESTROGEN ANTAGONISTS; ESTROGENS; HYPOTHALAMUS; LUCIFERASES; MALE; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STRESS, PSYCHOLOGICAL; SWIMMING; TAMOXIFEN; TRANSFECTION;

EID: 43949145228     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.03.016     Document Type: Article

References (43)

1. Abel E.L. Behavior and corticosteroid response of Maudsley reactive and nonreactive rats in the open field and forced swimming test. Physiol. Behav. 50 (1991) 151-153
2. Alves S.E., Lopez V., McEwen B.S., and Weiland N.G. Differential colocalization of estrogen receptor beta (ERbeta) with oxytocin and vasopressin in the paraventricular and supraoptic nuclei of the female rat brain: an immunocytochemical study. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 3281-3286
3. Antoni F.A. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front. Neuroendocrinol. 14 (1993) 76-122
4. Bao A.M., Fischer D.F., Wu Y.H., Hol E.M., Balesar R., Unmehopa U.A., Zhou J.N., and Swaab D.F. A direct androgenic involvement in the expression of human corticotropin-releasing hormone. Mol. Psychiatry. 11 (2006) 567-576
5. Bao A.M., Hestiantoro A., Van Someren E.J., Swaab D.F., and Zhou J.N. Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders. Brain 128 (2005) 1301-1313
6. Bao A.M., Meynen G., and Swaab D.F. The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res. Rev. (2007)
7. Bohus B., Benus R.F., Fokkema D.S., Koolhaas J.M., Nyakas C., van Oortmerssen G.A., Prins A.J., de Ruiter A.J., Scheurink A.J., and Steffens A.B. Neuroendocrine states and behavioral and physiological stress responses. Prog. Brain Res. 72 (1987) 57-70
8. Brush F.R. Genetic determinants of individual differences in avoidance learning: behavioral and endocrine characteristics. Experientia 47 (1991) 1039-1050
9. Burgess L.H., and Handa R.J. Chronic estrogen-induced alterations in adrenocorticotropin and corticosterone secretion, and glucocorticoid receptor-mediated functions in female rats. Endocrinology 131 (1992) 1261-1269
10. Cryan J.F., Markou A., and Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol. Sci. 23 (2002) 238-245
11. Fernandez-Guasti A., and Martinez-Mota L. Anxiolytic-like actions of testosterone in the burying behavior test: role of androgen and GABA-benzodiazepine receptors. Psychoneuroendocrinology 30 (2005) 762-770
12. Frye C.A., Edinger K., and Sumida K. Androgen administration to aged male mice increases anti-anxiety behavior and enhances cognitive performance. Neuropsychopharmacology (2007)
13. Gangloff A., Shi R., Nahoum V., and Lin S.X. Pseudo-symmetry of C19 steroids, alternative binding orientations, and multispecificity in human estrogenic 17beta-hydroxysteroid dehydrogenase. FASEB J. 17 (2003) 274-276
14. Harbuz M.S., Jessop D.S., Lightman S.L., and Chowdrey H.S. The effects of restraint or hypertonic saline stress on corticotrophin-releasing factor, arginine vasopressin, and proenkephalin A mRNAs in the CFY, Sprague-Dawley and Wistar strains of rat. Brain Res. 667 (1994) 6-12
15. Herman J.P., and Sherman T.G. Acute stress upregulates vasopressin gene expression in parvocellular neurons of the hypothalamic paraventricular nucleus. Ann. N. Y. Acad. Sci. 689 (1993) 546-549
16. Hrabovszky E., Kallo I., Hajszan T., Shughrue P.J., Merchenthaler I., and Liposits Z. Expression of estrogen receptor-beta messenger ribonucleic acid in oxytocin and vasopressin neurons of the rat supraoptic and paraventricular nuclei. Endocrinology 139 (1998) 2600-2604
17. Jiang Y.Q., Kawashima H., Iwasaki Y., Uchida K., Sugimoto K., and Itoi K. Differential effects of forced swim-stress on the corticotropin-releasing hormone and vasopressin gene transcription in the parvocellular division of the paraventricular nucleus of rat hypothalamus. Neurosci. Lett. 358 (2004) 201-204
18. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., and Gustafsson J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138 (1997) 863-870
19. Laflamme N., Nappi R.E., Drolet G., Labrie C., and Rivest S. Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: anatomical evidence of distinct roles of each subtype. J. Neurobiol. 36 (1998) 357-378
20. Liebsch G., Linthorst A.C., Neumann I.D., Reul J.M., Holsboer F., and Landgraf R. Behavioral, physiological, and neuroendocrine stress responses and differential sensitivity to diazepam in two Wistar rat lines selectively bred for high- and low-anxiety-related behavior. Neuropsychopharmacology 19 (1998) 381-396
21. Lund T.D., Hinds L.R., and Handa R.J. The androgen 5alpha-dihydrotestosterone and its metabolite 5alpha-androstan-3beta, 17beta-diol inhibit the hypothalamo-pituitary-adrenal response to stress by acting through estrogen receptor beta-expressing neurons in the hypothalamus. J. Neurosci. 26 (2006) 1448-1456
22. Lund T.D., Munson D.J., Haldy M.E., and Handa R.J. Dihydrotestosterone may inhibit hypothalamo-pituitary-adrenal activity by acting through estrogen receptor in the male mouse. Neurosci. Lett. 365 (2004) 43-47
23. Ma X.M., Levy A., and Lightman S.L. Rapid changes in heteronuclear RNA for corticotrophin-releasing hormone and arginine vasopressin in response to acute stress. J. Endocrinol. 152 (1997) 81-89
24. Mouri T., Itoi K., Takahashi K., Suda T., Murakami O., Yoshinaga K., Andoh N., Ohtani H., Masuda T., and Sasano N. Colocalization of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of the human hypothalamus. Neuroendocrinology 57 (1993) 34-39
25. Pak T.R., Chung W.C., Hinds L.R., and Handa R.J. Estrogen receptor-beta mediates dihydrotestosterone-induced stimulation of the arginine vasopressin promoter in neuronal cells. Endocrinology 148 (2007) 3371-3382
26. Pak T.R., Chung W.C., Lund T.D., Hinds L.R., Clay C.M., and Handa R.J. The androgen metabolite, 5alpha-androstane-3beta, 17beta-diol, is a potent modulator of estrogen receptor-beta1-mediated gene transcription in neuronal cells. Endocrinology 146 (2005) 147-155
27. Plotsky P.M. Pathways to the secretion of adrenocorticotropin: a view from the portal. J. Neuroendocrinol. 3 (1991) 1-9
28. Porsolt R.D., Anton G., Blavet N., and Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47 (1978) 379-391
29. Porsolt R.D., Le Pichon M., and Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 266 (1977) 730-732
30. Raven P.W., and Taylor N.F. 11Beta-HSD and 17beta-HSD as biological markers of depression: sex differences and correlation with symptom severity. Endocr. Res. 24 (1998) 659-662
31. Schule C., Romeo E., Uzunov D.P., Eser D., di Michele F., Baghai T.C., Pasini A., Schwarz M., Kempter H., and Rupprecht R. Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity. Mol. Psychiatry 11 (2006) 261-272
32. Shapiro R.A., Xu C., and Dorsa D.M. Differential transcriptional regulation of rat vasopressin gene expression by estrogen receptor alpha and beta. Endocrinology 141 (2000) 4056-4064
33. Steckelbroeck S., Jin Y., Gopishetty S., Oyesanmi B., and Penning T.M. Human cytosolic 3alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action. J. Biol. Chem. 279 (2004) 10784-10795
34. Torn S., Nokelainen P., Kurkela R., Pulkka A., Menjivar M., Ghosh S., Coca-Prados M., Peltoketo H., Isomaa V., and Vihko P. Production, purification, and functional analysis of recombinant human and mouse 17beta-hydroxysteroid dehydrogenase type 7. Biochem. Biophys. Res. Commun. 305 (2003) 37-45
35. Tramu G., Croix C., and Pillez A. Ability of the CRF immunoreactive neurons of the paraventricular nucleus to produce a vasopressin-like material. Immunohistochemical demonstration in adrenalectomized guinea pigs and rats. Neuroendocrinology 37 (1983) 467-469
36. Vamvakopoulos N.C., and Chrousos G.P. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimorphism of the stress response and immune/inflammatory reaction. J. Clin. Invest. 92 (1993) 1896-1902
37. Walf A.A., and Frye C.A. Antianxiety and antidepressive behavior produced by physiological estradiol regimen may be modulated by hypothalamic-pituitary-adrenal axis activity. Neuropsychopharmacology 30 (2005) 1288-1301
38. Weihua Z., Andersson S., Cheng G., Simpson E.R., Warner M., and Gustafsson J.A. Update on estrogen signaling. FEBS Lett. 546 (2003) 17-24
39. Weihua Z., Lathe R., Warner M., and Gustafsson J.A. An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 13589-13594
40. Weihua Z., Makela S., Andersson L.C., Salmi S., Saji S., Webster J.I., Jensen E.V., Nilsson S., Warner M., and Gustafsson J.A. A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 6330-6335
41. Whitnall M.H. Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog. Neurobiol. 40 (1993) 573-629
42. Yasin S.A., Costa A., Besser G.M., Hucks D., Grossman A., and Forsling M.L. Melatonin and its analogs inhibit the basal and stimulated release of hypothalamic vasopressin and oxytocin in vitro. Endocrinology 132 (1993) 1329-1336
43. Young E.A., Altemus M., Parkinson V., and Shastry S. Effects of estrogen antagonists and agonists on the ACTH response to restraint stress in female rats. Neuropsychopharmacology 25 (2001) 881-891